DelveInsight’s “Opioid Use Disorder Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Opioid Use Disorder, historical and forecasted epidemiology as well as the Opioid Use Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Opioid Use Disorder market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

To Know in detail about the Opioid Use Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Opioid Use Disorder Market Insights

Opioid Use Disorder Overview

Opioids, generally prescribed as pain relievers, are natural or synthetic chemicals that bind to opioid receptors in the central nervous system and can reduce feelings of pain. Along with a depressant effect on the CNS, they also have the potential to cause euphoria. Misuse or overdose of prescribed opioid medications refer to ‘Opioid use disorder (OUD) ‘.

Some of the key facts of the Opioid Use Disorder Market Report:  

• The Opioid Use Disorder market size is anticipated to grow with a significant CAGR during the study period (2019-2032) 
• Opioid use disorders affect over 16 million people worldwide, over 2.1 million in the United States, and there are over 1,20,000 deaths worldwide annually attributed to opioids 
• According to American Psychiatric Association, around 72,000 people in the United States have died of overdose of drugs, which included illicit drugs and prescription opioids 
• According to the World Health Organization (WHO), the annual global prevalent pool of opioid abusers was estimated at between 28 and 38 million users 
• Key Opioid Use Disorder Companies: Trevena, Opiate Pharmaceutical, APH-1501, and others
• Key Opioid Use Disorder Therapies: TRV734, Nalmefene (OPNTOO3), Aphios, and others 

Get a Free sample for the Opioid Use Disorder Market Report- 

https://www.delveinsight.com/sample-request/opioid-use-disorder-market

Key benefits of the Opioid Use Disorder Market report:

1. Opioid Use Disorder market report covers a descriptive overview and comprehensive insight of the Opioid Use Disorder Epidemiology and Opioid Use Disorder market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Opioid Use Disorder market report provides insights on the current and emerging therapies.
3. Opioid Use Disorder market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Opioid Use Disorder market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Opioid Use Disorder market.

Download the report to understand which factors are driving Opioid Use Disorder epidemiology trends @ Opioid Use Disorder Epidemiological Insights 

Opioid Use Disorder Market  

The dynamics of the Opioid Use Disorder market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“DemeRx, Inc. is a clinical stage pharmaceutical company developing ibogaine (DMX-IB1) and noribogaine (DMX-NB1) as oral, non-addicting treatments for opioid dependence.” 

Opioid Use Disorder Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Opioid Use Disorder Epidemiology Segmentation:

The Opioid Use Disorder market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Opioid Use Disorder
• Prevalent Cases of Opioid Use Disorder by severity
• Gender-specific Prevalence of Opioid Use Disorder
• Diagnosed Cases of Episodic and Chronic Opioid Use Disorder

Opioid Use Disorder Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Opioid Use Disorder market or expected to get launched during the study period. The analysis covers Opioid Use Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Opioid Use Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Discover more about therapies set to grab major Opioid Use Disorder market share @ Opioid Use Disorder market forecast 

Opioid Use Disorder Therapies and Key Companies

• TRV734: Trevena
• Nalmefene (OPNTOO3): Opiate Pharmaceutical
• Aphios: APH-1501

Opioid Use Disorder Market Drivers

• Important progress has been made regarding understanding disease pathology, diagnosis, and treatment effects in Opioid Use Disorder
• Newborn screening for Opioid Use Disorder has been implemented in several countries, enabling the early detection of individuals with Fabry mutations 

Scope of the Opioid Use Disorder Market Report

• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Opioid Use Disorder Companies: Trevena, Opiate Pharmaceutical, APH-1501, and others
• Key Opioid Use Disorder Therapies: TRV734, Nalmefene (OPNTOO3), Aphios, and others
• Opioid Use Disorder Therapeutic Assessment: Opioid Use Disorder current marketed and Opioid Use Disorder emerging therapies
• Opioid Use Disorder Market Dynamics: Opioid Use Disorder market drivers and Opioid Use Disorder market barriers 
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Opioid Use Disorder Unmet Needs, KOL’s views, Analyst’s views, Opioid Use Disorder Market Access and Reimbursement 

Opioid Use Disorder Market Unmet Needs

• Challenges in diagnoses
• Development of novel therapies
• Limitations in gene therapy
• Poor disease understanding
• Clinical biomarkers 

Table of Contents 

1. Opioid Use Disorder Market Report Introduction

2. Executive Summary for Opioid Use Disorder

3. SWOT analysis of Opioid Use Disorder

4. Opioid Use Disorder Patient Share (%) Overview at a Glance

5. Opioid Use Disorder Market Overview at a Glance

6. Opioid Use Disorder Disease Background and Overview

7. Opioid Use Disorder Epidemiology and Patient Population

8. Country-Specific Patient Population of Opioid Use Disorder 

9. Opioid Use Disorder Current Treatment and Medical Practices

10. Opioid Use Disorder Unmet Needs

11. Opioid Use Disorder Emerging Therapies

12. Opioid Use Disorder Market Outlook

13. Country-Wise Opioid Use Disorder Market Analysis (2019–2032)

14. Opioid Use Disorder Market Access and Reimbursement of Therapies

15. Opioid Use Disorder Market Drivers

16. Opioid Use Disorder Market Barriers

17.  Opioid Use Disorder Appendix

18. Opioid Use Disorder Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

To know more about Opioid Use Disorder treatment, visit @ Opioid Use Disorder Medications

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV 89107
Country: United States
Website: https://www.delveinsight.com/consulting